CTOs on the Move


 
In 2010, Yogen Dalal, after being diagnosed, co-founded Glooko with the mission to make diabetes management easier by liberating data from diabetes devices to help patients and providers to make smarter decisions.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.glooko.com
  • 899 W. Evelyn Avenue
    Mountain View, CA USA 94041
  • Phone: 650.720.5310

Executives

Name Title Contact Details
Lavanya Elangovan
VP, Engineering Profile

Funding

Glooko raised $36M on 09/14/2016
Glooko raised $35M on 06/27/2017

Similar Companies

Amplifyd

Amplifyd is a company that builds tools to connect people with their favorite artists through online and in-person experiences, merchandise, VIP access, events, digital content, and more. They also have two platforms, Amplifyd Voices and Amplifyd Pledg...

NetSynergy Virtual Solutions

Who is NETSVS? Founded in 2008, NETSVS is strongly focused on harnessing the power of unstructured or dissimilar data through the ETL process. Through experience and constant education, NETSVS has managed to build a team that excels in the various s...

BrokerPriceOpinion.com

BrokerPriceOpinion.com is a Westminster, CO-based company in the Software and Internet sector.

Senzit

Increase your fleets uptime, reduce wasted resources, & upgrade your PMs with Senzit. Monitor the health and location of every machine, across every site.

OmniComm

Businesses are finding themselves faced with transformative change, from cloud technology to big data. No better example than the life sciences industry which is transforming from a data-driven clinical enterprise to an information-driven one. As the EDC specialists OmniComm understands the power that an information-driven clinical enterprise can bring to your clinical research organization. OmniComm is the only company that provides our clients with a choice of best-of-breed EDC platforms that are purpose-built for their unique clinical research environments – Early Phase, Late Phase, Phase I-IV, device trials, Investigator Initiated. We bring the most advanced open and interoperable EDC platforms to our clients; through our innovative cloud technology and advanced API web services we provide our clients with information to make insight driven clinical data-based critical decisions, bringing medical therapies to patients faster with lower risk. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from over 4,800 clinical trials. 4 of the 5 top CROs and 7 of the 10 largest Phase I Clinics run OmniComm EDC technologies.